-
公开(公告)号:US20190070117A1
公开(公告)日:2019-03-07
申请号:US16182868
申请日:2018-11-07
Applicant: Merial, Inc.
Inventor: Noel Yves Henri Jean Genin
Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for vitrifying biological preparations, including peptides, antigens, antibodies, cells, and the like.
-
公开(公告)号:US10213509B2
公开(公告)日:2019-02-26
申请号:US16125911
申请日:2018-09-10
Applicant: Merial, Inc.
Inventor: Noel Yves Henri Jean Genin
IPC: A61K47/26 , A61K9/46 , A61K9/00 , A61K39/00 , A61K39/12 , A61K39/17 , A61K39/215 , A61K39/255 , A61K39/275 , A61K9/20
Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
-
公开(公告)号:US10206928B2
公开(公告)日:2019-02-19
申请号:US15801109
申请日:2017-11-01
Applicant: MERIAL INC.
Inventor: Rolf Valter Attstrom , Hugo De Bruyn
IPC: A61K31/5377 , A61K8/49 , A61Q11/00
Abstract: Use of a compound having the formula (I) in a medicament for the prevention or treatment of a disease caused by oral bacteria in an animal wherein R1 is a straight or branched alkyl group containing 8 to 16 carbon atoms at the 2- or 3-position of the morpholino ring, and R2 is a straight or branched alkyl group containing 2 to 10 carbon atoms, substituted with a hydroxy group except in the alpha-position, or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20180354917A1
公开(公告)日:2018-12-13
申请号:US15946642
申请日:2018-04-05
Applicant: MERIAL INC.
Inventor: Roelof Johannes Gorter de Vries , Bruno Baillon , Sylvaine Lafont , Myriam Gay de Saint Michel , Stephane Kozlovic
IPC: C07D261/04
Abstract: The present invention provides crystalline forms of compound of formula (Ia) and processes of making the crystalline forms. Also provided are compositions comprising the crystalline forms and methods of use of the crystalline forms.
-
公开(公告)号:US20180304061A1
公开(公告)日:2018-10-25
申请号:US15769664
申请日:2016-10-21
Applicant: MERIAL INC.
Inventor: Christophe Sautereau
CPC classification number: A61M35/003 , A61J1/065 , A61M39/00 , B65D1/09
Abstract: A storage and manual dispenser apparatus for dispensing a pharmaceutical liquid under atmospheric pressure. This apparatus retains the liquid in a controlled and stable environment during storage.
-
公开(公告)号:US10080798B2
公开(公告)日:2018-09-25
申请号:US15265545
申请日:2016-09-14
Applicant: MERIAL, INC.
Inventor: Frederic David , Zahia Hannas-Djebbara , Herve Poulet , Jules Maarten Minke
IPC: A61K39/23 , C07K14/005 , C12N7/00 , A61K39/135 , A61K39/12 , A61K39/00
CPC classification number: A61K39/23 , A61K39/12 , A61K39/135 , A61K2039/525 , A61K2039/5258 , A61K2039/545 , A61K2039/552 , A61K2039/575 , A61K2039/70 , C07K14/005 , C12N7/00 , C12N2750/14323 , C12N2750/14334 , C12N2750/14371 , C12N2770/32123 , C12N2770/32134
Abstract: The present invention encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs provided by the invention are formed by the CPV VP2 protein. Further, the invention broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.
-
7.
公开(公告)号:US10071582B2
公开(公告)日:2018-09-11
申请号:US15498933
申请日:2015-10-30
Applicant: MERIAL INC.
Inventor: Andy Brehm , Julie Campbell , Ed Schindler , Dennis Jerome Freeman
CPC classification number: B41M5/24 , A61J1/18 , A61J2200/44 , B41J3/4075 , B41M5/26 , B41M5/267
Abstract: This invention relates to an apparatus and method for applying writings and other markings to a frozen vial or ampoule, which is filled with biological material, and which is held at temperatures between about −70° C. and about −196° C. More particularly, the invention relates to a laser marking method that allows frozen vials to be labeled, while maintaining the integrity of the biological material contained therein.
-
公开(公告)号:US20180250382A1
公开(公告)日:2018-09-06
申请号:US15846735
申请日:2016-06-23
Applicant: MERIAL INC.
Inventor: Yu-Wei Chiang , David Cureton , Herve Poulet
IPC: A61K39/145 , A61P31/16 , G01N33/569
CPC classification number: A61K39/145 , A61K39/12 , A61K2039/5252 , A61K2039/552 , A61K2039/55505 , A61K2039/55566 , A61K2039/70 , A61P31/16 , C12N2760/16134 , G01N33/56983
Abstract: The present invention relates to canine influenza virus strains, and vaccines and compositions. The present invention also relates to reagents and methods allowing their detection, methods of vaccination as well as methods of producing these reagents and vaccines.
-
9.
公开(公告)号:US20180185336A1
公开(公告)日:2018-07-05
申请号:US15904798
申请日:2018-02-26
Applicant: MERIAL INC.
Inventor: Mark David Soll , Diane Larsen , Susan Mancini Cady , Peter Cheifetz , Izabela Galeska , Saijun Gong
IPC: A61K31/42 , A61K31/365 , A61K31/4985 , A61K31/27 , A61K31/437 , A61K9/00 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/32 , A61K47/36 , A61K47/44 , A61K31/7048 , C07D261/04 , A61K45/06 , A23K20/00 , A61K47/42 , A61K31/325 , A01N43/80 , A61K31/194
Abstract: This invention relates to oral veterinary compositions for combating ectoparasites and endoparasites in animals, comprising at least one systemically-acting active agent in combination with a pharmaceutically acceptable carrier. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.
-
公开(公告)号:US10010605B2
公开(公告)日:2018-07-03
申请号:US14863181
申请日:2015-09-23
Applicant: MERIAL, INC.
Inventor: Jean-Christophe Audonnet , Zahia Hannas-Djebbara , Teshome Mebatsion , Yu-Wei Chiang , Justin Widener , Frédéric Reynard
IPC: A61K39/135 , A61K39/12 , C07K14/005 , C12N7/00 , A61K39/00
CPC classification number: A61K39/135 , A61K39/12 , A61K2039/5258 , A61K2039/545 , A61K2039/55577 , C07K14/005 , C12N7/00 , C12N2710/10043 , C12N2710/14043 , C12N2770/32123 , C12N2770/32134
Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
-
-
-
-
-
-
-
-
-